RespireRx Pharmaceuticals Inc (fka RSPI)

[gfp927z]

Erik, So maybe we were better off with the devil we knew? I can't imagine Schering being any slower than Organon though. Of course it would have been better if an AMPA oriented BP had bought Organon. As we know, the list is growing - Lilly, Glaxo, and more recently Sanofi Aventis had some AMPA upregulation patents, plus Merck might conceivably be entering the picture.

Hope you are still doing your annual bike trips. I was in Scotland last Fall (non-biking). Will hopefully be getting into Scandinavia one of these years to explore Norway and Sweden where my ancestors were from. Good to see you still interested in Cortex.